MAPT and tauopathy: In mouse studies, both APOE4 as well as APOE2 increased tauopathy burden in two different mouse models [11, 12], raising intriguing possibilities of how APOE might interact with tau in the presence of co-morbidities (such as Aβ and α-synuclein).